The Experts below are selected from a list of 626235 Experts worldwide ranked by ideXlab platform
Mats Borjesson - One of the best experts on this subject based on the ideXlab platform.
-
recommendations for participation in leisure time or competitive sports in athletes patients with coronary artery disease a position statement from the sports Cardiology section of the european association of preventive Cardiology eapc
European Heart Journal, 2019Co-Authors: Mats Borjesson, Josef Niebauer, Andre Lagerche, Christian Schmied, Erik Ekker Solberg, Martin Halle, Paolo Emilio Adami, Mikael Dellborg, Alessandro BiffiAbstract:This paper presents a brief summary of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology (EAPC) on sports-participation in patients with co...
-
Position paper: proposal for a core curriculum for a European Sports Cardiology qualification.
European Journal of Preventive Cardiology, 2013Co-Authors: Hein Heidbuchel, Mats Borjesson, Michael Papadakis, Nicole Panhuyzen-goedkoop, François Carré, Dorian Dugmore, Klaus-peter Mellwig, Hanne Kruuse Rasmusen, Erik E Solberg, Domenico CorradoAbstract:Sports Cardiology is a new and rapidly evolving subspecialty. It aims to elucidate the cardiovascular effects of regular exercise and delineate its benefits and risks, so that safe guidance can be provided to all individuals engaging in sports and/or physical activity in order to attain the maximum potential benefit at the lowest possible risk. The European Society of Cardiology (ESC) advocates systematic preparticipation cardiovascular screening in an effort to identify competitive athletes at risk of exercise-related cardiovascular events and sudden cardiac death. However, the implementation of preparticipation screening is hindered because of lack of structured training and as a result lack of sufficient expertise in the field of sports Cardiology. In 2008 the European Society of Cardiology published a core curriculum for the general cardiologist, in which sports Cardiology was incorporated within the topic 'Rehabilitation and Exercise Physiology'. However, the exponential rise in knowledge and the growing demand for expertise in the field of sports Cardiology dictates the need to systematically structure the knowledge base of sports Cardiology into a detailed curriculum. We envisage that the curriculum would facilitate more uniform training and guideline implementation throughout Europe, and safeguard that evaluation and guidance of competitive athletes or individuals who wish to engage in leisure-time sports activities is performed by physicians with expertise in the field. The current manuscript provides a comprehensive curriculum for sports Cardiology, which may serve as a framework upon which universities and national and international health authorities will develop the training, evaluation and accreditation in sports Cardiology.
Ian B. A. Menown - One of the best experts on this subject based on the ideXlab platform.
-
Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials
Advances in Therapy, 2021Co-Authors: Aileen Kearney, Katie Linden, Patrick Savage, Ian B. A. MenownAbstract:Introduction Despite the challenge of a global pandemic, 2020 has been an invaluable year in Cardiology research with numerous important clinical trials published or presented virtually at major international meetings. This article aims to summarise these trials and place them in clinical context. Methods The authors reviewed clinical trials presented at major Cardiology conferences during 2020 including the American College of Cardiology, European Association for Percutaneous Cardiovascular Interventions, European Society of Cardiology, Transcatheter Cardiovascular Therapeutics and the American Heart Association. Trials with a broad relevance to the Cardiology community and those with potential to change current practice were included. Results A total of 87 key Cardiology clinical trials were identified for inclusion. New interventional and structural Cardiology data included trials evaluating bifurcation percutaneous coronary intervention (PCI) techniques, intravascular ultrasound (IVUS)-guided PCI, instantaneous wave-free (iFR) physiological assessment, new generation stents (DynamX bioadaptor), transcatheter aortic valve implantation (TAVI) in low-risk patients, and percutaneous mitral or tricuspid valve interventions. Preventative Cardiology data included new data with proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitors (evolocumab and alirocumab), omega-3 supplements, evinacumab and colchicine in the setting of chronic coronary artery disease. Antiplatelet data included trials evaluating both the optimal length of course following PCI and combination of antiplatelet agents and regimes including combination antithrombotic therapies for patients with atrial fibrillation (AF). Heart failure data included the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors (sotagliflozin, empagliflozin and dapagliflozin) and mavacamten in hypertrophic cardiomyopathy. Electrophysiology trials included early rhythm control in AF and screening for AF. Conclusion This article presents a summary of key clinical Cardiology trials during the past year and should be of relevance to both clinicians and Cardiology researchers.
-
Advances in Clinical Cardiology 2017: A Summary of Key Clinical Trials
Advances in Therapy, 2018Co-Authors: Conor Mcquillan, Aileen Kearney, Alastair Gray, Ian B. A. MenownAbstract:INTRODUCTION Numerous important Cardiology clinical trials have been published or presented at major international meetings during 2017. This paper aims to summarize these trials and place them in clinical context. METHODS The authors reviewed clinical trials presented at major Cardiology conferences during 2017 including the American College of Cardiology, European Association for Percutaneous Cardiovascular Interventions, European Society of Cardiology, European Association for the Study of Diabetes, Transcatheter Cardiovascular Therapeutics, and the American Heart Association. Selection criteria were trials with a broad relevance to the Cardiology community and those with potential to change current practice. RESULTS A total of 75 key Cardiology clinical trials were identified for inclusion. New interventional and structural Cardiology data include left main bifurcation treatment strategy, multivessel disease management in cardiogenic shock, drug-eluting balloons for in-stent restenosis, instantaneous wave-free physiological assessment, new-generation stents (COMBO, Orsiro), transcatheter aortic valve implantation, and closure devices. New preventative Cardiology data include trials of liraglutide, empagliflozin, PCSK9 inhibitors (evolocumab and bococizumab), inclisiran, and anacetrapib. Antiplatelet data include the role of uninterrupted aspirin therapy during non-cardiac surgery and dual antiplatelet therapy following coronary artery bypass grafting. New data are also included from fields of heart failure (levosimendan, spironolactone), atrial fibrillation (apixaban in DC cardioversion), cardiac devices (closed loop stimulation pacing for neuromediated syncope), and electrophysiology (catheter ablation for atrial fibrillation). CONCLUSION This paper presents a summary of key clinical Cardiology trials during the past year and should be of practical value to both clinicians and Cardiology researchers.
-
Advances in Clinical Cardiology 2016: A Summary of the Key Clinical Trials
Advances in Therapy, 2017Co-Authors: Alastair Gray, Conor Mcquillan, Ian B. A. MenownAbstract:Introduction The findings of many new Cardiology clinical trials over the last year have been published or presented at major international meetings. This paper aims to describe and place in context a summary of the key clinical trials in Cardiology presented between January and December 2016. Methods The authors reviewed clinical trials presented at major Cardiology conferences during 2016 including the American College of Cardiology (ACC), European Association for Percutaneous Cardiovascular Interventions (EuroPCR), European Society of Cardiology (ESC), European Association for the Study of Diabetes (EASD), Transcatheter Cardiovascular Therapeutics (TCT), and the American Heart Association (AHA). Selection criteria were trials with a broad relevance to the Cardiology community and those with potential to change current practice. Results A total of 57 key Cardiology clinical trials were identified for inclusion. Here we describe and place in clinical context the key findings of new data relating to interventional and structural Cardiology including delayed stenting following primary angioplasty, contrast-induced nephropathy, management of jailed wires, optimal duration of dual antiplatelet therapy (DAPT), stenting vs bypass for left main disease, new generation stents (BioFreedom, Orsiro, Absorb), transcatheter aortic valve implantation (Edwards Sapien XT, transcatheter embolic protection), and closure devices (Watchman, Amplatzer). New preventative Cardiology data include trials of bariatric surgery, empagliflozin, liraglutide, semaglutide, PCSK9 inhibitors (evolocumab and alirocumab), and inclisiran. Antiplatelet therapy trials include platelet function monitoring and ticagrelor vs clopidogrel for peripheral vascular disease. New data are also presented in fields of heart failure (sacubitril/valsartan, aliskiren, spironolactone), atrial fibrillation (rivaroxaban in patients undergoing coronary intervention, edoxaban in DC cardioversion), cardiac devices (implantable cardioverter defibrillator in non-ischemic cardiomyopathy), and electrophysiology (cryoballoon vs radiofrequency ablation). Conclusion This paper presents a summary of key clinical Cardiology trials during the past year and should be of practical value to both clinicians and Cardiology researchers.
Domenico Corrado - One of the best experts on this subject based on the ideXlab platform.
-
Position paper: proposal for a core curriculum for a European Sports Cardiology qualification.
European Journal of Preventive Cardiology, 2013Co-Authors: Hein Heidbuchel, Mats Borjesson, Michael Papadakis, Nicole Panhuyzen-goedkoop, François Carré, Dorian Dugmore, Klaus-peter Mellwig, Hanne Kruuse Rasmusen, Erik E Solberg, Domenico CorradoAbstract:Sports Cardiology is a new and rapidly evolving subspecialty. It aims to elucidate the cardiovascular effects of regular exercise and delineate its benefits and risks, so that safe guidance can be provided to all individuals engaging in sports and/or physical activity in order to attain the maximum potential benefit at the lowest possible risk. The European Society of Cardiology (ESC) advocates systematic preparticipation cardiovascular screening in an effort to identify competitive athletes at risk of exercise-related cardiovascular events and sudden cardiac death. However, the implementation of preparticipation screening is hindered because of lack of structured training and as a result lack of sufficient expertise in the field of sports Cardiology. In 2008 the European Society of Cardiology published a core curriculum for the general cardiologist, in which sports Cardiology was incorporated within the topic 'Rehabilitation and Exercise Physiology'. However, the exponential rise in knowledge and the growing demand for expertise in the field of sports Cardiology dictates the need to systematically structure the knowledge base of sports Cardiology into a detailed curriculum. We envisage that the curriculum would facilitate more uniform training and guideline implementation throughout Europe, and safeguard that evaluation and guidance of competitive athletes or individuals who wish to engage in leisure-time sports activities is performed by physicians with expertise in the field. The current manuscript provides a comprehensive curriculum for sports Cardiology, which may serve as a framework upon which universities and national and international health authorities will develop the training, evaluation and accreditation in sports Cardiology.
Alessandro Biffi - One of the best experts on this subject based on the ideXlab platform.
-
recommendations for participation in leisure time or competitive sports in athletes patients with coronary artery disease a position statement from the sports Cardiology section of the european association of preventive Cardiology eapc
European Heart Journal, 2019Co-Authors: Mats Borjesson, Josef Niebauer, Andre Lagerche, Christian Schmied, Erik Ekker Solberg, Martin Halle, Paolo Emilio Adami, Mikael Dellborg, Alessandro BiffiAbstract:This paper presents a brief summary of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology (EAPC) on sports-participation in patients with co...
H. T. Jørstad - One of the best experts on this subject based on the ideXlab platform.
-
The Netherlands Sports Cardiology Map: a step towards sports Cardiology network medicine for patient and athlete care
Netherlands Heart Journal, 2020Co-Authors: J. C. Van Hattum, S. M. Verwijs, R. Rienks, N. R. Bijsterveld, S. T. De Vries, Y. M. Pinto, A. A. M. Wilde, H. T. JørstadAbstract:Sports Cardiology is a rapidly evolving subspecialty of Cardiology, with a growing demand for expertise. To improve patient care, clinicians, patients, and athletes (recreational to elite) should be able to easily identify specialised care pathways, expertise centres and clinicians with sports Cardiology expertise. To this purpose, several international societies and organisations recommend establishing a local and national sports Cardiology infrastructure. We therefore aimed to establish The Netherlands Sports Cardiology Map. We conducted a web-based survey, which was published on the Netherlands Society of Cardiology home page (2019–2020) and in which each Cardiology department or clinic was asked to provide information on sports Cardiology expertise and the current infrastructure. Of the 46 respondent centres, 28 (61%) reported that they had expertise in sports Cardiology, of which 22 (79%) had specific expertise in one or more specific types of sports. Integrated multidisciplinary meetings were reported by 43% of the centres ( n = 12/28). Only two centres reported ongoing research projects that had been approved by an institutional review board. The Netherlands Sports Cardiology Map is an important step towards improving the existing infrastructure and developing network medicine for sports Cardiology.
-
The Netherlands Sports Cardiology Map: a step towards sports Cardiology network medicine for patient and athlete care.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2020Co-Authors: J. C. Van Hattum, S. M. Verwijs, R. Rienks, N. R. Bijsterveld, S. T. De Vries, Y. M. Pinto, A. A. M. Wilde, H. T. JørstadAbstract:Sports Cardiology is a rapidly evolving subspecialty of Cardiology, with a growing demand for expertise. To improve patient care, clinicians, patients, and athletes (recreational to elite) should be able to easily identify specialised care pathways, expertise centres and clinicians with sports Cardiology expertise. To this purpose, several international societies and organisations recommend establishing a local and national sports Cardiology infrastructure. We therefore aimed to establish The Netherlands Sports Cardiology Map. We conducted a web-based survey, which was published on the Netherlands Society of Cardiology home page (2019-2020) and in which each Cardiology department or clinic was asked to provide information on sports Cardiology expertise and the current infrastructure. Of the 46 respondent centres, 28 (61%) reported that they had expertise in sports Cardiology, of which 22 (79%) had specific expertise in one or more specific types of sports. Integrated multidisciplinary meetings were reported by 43% of the centres (n = 12/28). Only two centres reported ongoing research projects that had been approved by an institutional review board. The Netherlands Sports Cardiology Map is an important step towards improving the existing infrastructure and developing network medicine for sports Cardiology.
